Pasar al contenido principal

NADPH OXIDASAS, METABOLISMO Y SEÑALIZACION REDOX EN LEUCEMIAS MIELOIDES

PID2020-117692RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SALAMANCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NOX2 and NOX4 control mitochondrial function in chronic myeloid leukaemia

  • Romo-González, Marta
  • Ijurko, Carla
  • Alonso, María Teresa
  • Gómez de Cedrón, Marta
  • Ramirez, Ana
  • Soriano, María Eugenia
  • Hernández-Hernández, Ángel
Cancer cells are characterised by an elevated metabolic plasticity and enhanced production of reactive oxygen species (ROS), two features acknowledged as hallmarks in cancer, with a high translational potential to the therapeutic setting. These aspects, that have been traditionally studied separately, are in fact intimately intermingled. As part of their transforming activity, some oncogenes stimulate rewiring of metabolic processes, whilst simultaneously promoting increased production of intracellular ROS. In this scenario the latest discoveries suggest the relevance of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOX) to connect ROS production and metabolic control. Here we have analysed the relevance of NOX2 and NOX4 in the regulation of metabolism in chronic myeloid leukaemia (CML), a neoplasia driven by the expression of the breakpoint cluster region-Abelson fusion oncogene (BCR-ABL). Silencing of NOX2 enhances glycolysis and oxidative phosphorylation rates, together with an enhanced production of mitochondrial ROS and a decrease in mitochondrial DNA copy number, which reflects mitochondrial dysfunction. NOX4 expression was upregulated upon NOX2 silencing, and this was required to alter mitochondrial function. Our results support the relevance of NOX2 to regulate metabolism-related signalling pathways downstream of BCR-ABL. Overall we show that NOX2, through the regulation of NOX4 expression, controls metabolism and mitochondrial function in CML cells. This notion was confirmed by transcriptomic analyses, that strongly relate both NOX isoforms with metabolism regulation in CML., Marta Romo-González and Carla Ijurko were recipient of pre-doctoral fellowships from the Regional Government of Castile and Leon, Spain and ERDF funds. Funding sources were as follows: Angel Hernández-Hernández lab: Spanish Government (PID2020-117692RB-I00), Regional Government of Castile & Leon (SA077P20) and Ramón Areces Foundation (CIV17A2822). Ana Ramirez de Molina lab: Spanish Government (PID2019-110183RB-C21), Regional Government of Community of Madrid (P2018/BAA-4343-ALIBIRD2020-CM), Synergistic Projects Community of Madrid NUTRISION-CM/Y2020/BIO-6350. Maria Teresa Alonso lab: Spanish Government (PID2020-116086RB-I00)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

NOX2 control over energy metabolism plays a role in acute myeloid leukaemia prognosis and survival

  • Ijurko, Carla
  • Romo-González, Marta
  • García-Calvo, Clara
  • Sardina, José Luis|||0000-0002-8493-3937
  • Sánchez-Bernal, Carmen
  • Sánchez-Yagüe, Jesús
  • Elena-Herrmann, Bénédicte
  • Villaret, Joran
  • Garrel, Catherine
  • Mondet, Julie
  • Mossuz, Pascal
  • Hernández-Hernández, Ángel
Acute myeloid leukaemia (AML) is a highly heterogeneous disease, however the therapeutic approaches have hardly changed in the last decades. Metabolism rewiring and the enhanced production of reactive oxygen species (ROS) are hallmarks of cancer. A deeper understanding of these features could be instrumental for the development of specific AML-subtypes treatments. NADPH oxidases (NOX), the only cellular system specialised in ROS production, are also involved in leukemic metabolism control. NOX2 shows a variable expression in AML patients, so patients can be classified based on such difference. Here we have analysed whether NOX2 levels are important for AML metabolism control. The lack of NOX2 in AML cells slowdowns basal glycolysis and oxidative phosphorylation (OXPHOS), along with the accumulation of metabolites that feed such routes, and a sharp decrease of glutathione. In addition, we found changes in the expression of 725 genes. Among them, we have discovered a panel of 30 differentially expressed metabolic genes, whose relevance was validated in patients. This panel can segregate AML patients according to CYBB expression, and it can predict patient prognosis and survival. In summary, our data strongly support the relevance of NOX2 for AML metabolism, and highlights the potential of our discoveries in AML prognosis.